4AB:ETR
AbbVie Common Stock
266,20 €
arrow_downward
-1,55%(-4,20) 1D
17 қар., 17:35:46 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
267,20 €
High
268,00 €
Low
264,50 €
Mkt. cap
516,30 млрд
Avg. vol.
603,00
Volume
215,00
52-wk high
272,20 €
52-wk low
162,85 €
No. of employees
57 мың
Open
267,20 €
High
268,00 €
Low
264,50 €
Mkt. cap
516,30 млрд
Avg. vol.
603,00
Volume
215,00
52-wk high
272,20 €
52-wk low
162,85 €
No. of employees
57 мың
News stories
From web sources and news partners
CNBC
·
1 сағат бұрын
Final Trades: Berkshire Hathaway, Amazon, AbbVie and Marriott
Yahoo Finance
·
2 сағат бұрын
How Did AbbVie's Neuroscience Franchise Perform in Q3?
The Globe and Mail
·
10 сағат бұрын
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Yahoo Finance
·
3 күн бұрын
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websiteabbvie.com